Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Net Income towards Common Stockholders (2009 - 2026)

Updated

Bristol Myers Squibb's Net Income towards Common Stockholders was $2.16 billion in Q3 2026, down 1.8% from $2.2 billion a year earlier and down 34.8% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Bristol Myers Squibb's Net Income towards Common Stockholders was $9.24 billion through Sep 30, 2026, up 53.1% year-over-year; for FY2025, it came in at $7.05 billion.

  • In earlier years, Net Income towards Common Stockholders was -$8.95 billion in FY2024, $8.03 billion in FY2023 (+26.8%), $6.33 billion in FY2022 (-9.5%) and $6.99 billion in FY2021.
  • Quarterly Net Income towards Common Stockholders has moved between -$11.91 billion (Q1 2024) and $3.32 billion (Q2 2026) over five years.
  • Compared with a year earlier, Net Income towards Common Stockholders was higher in three of the last six quarters, with growth averaging 20.7%.
  • The best year-over-year quarter for Net Income towards Common Stockholders over five years was Q2 2026 (growth of 153.2%); the worst was Q4 2024 (a decline of 95.9%).
  • Per Business Quant data, BMY's Net Income towards Common Stockholders in the three quarters before Q3 2026 was $3.32 billion (Q2 2026), $2.68 billion (Q1 2026) and $1.09 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.12 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.24 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 2.16 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.16 Bn
Jun 30, 2026 3.32 Bn
Mar 31, 2026 2.68 Bn
Dec 31, 2025 1.09 Bn
Sep 30, 2025 2.20 Bn
Jun 30, 2025 1.31 Bn
Mar 31, 2025 2.46 Bn
Dec 31, 2024 72.00 Mn
Sep 30, 2024 1.21 Bn
Jun 30, 2024 1.68 Bn
Mar 31, 2024 -11.91 Bn
Dec 31, 2023 1.76 Bn
Sep 30, 2023 1.93 Bn
Jun 30, 2023 2.07 Bn
Mar 31, 2023 2.26 Bn
Dec 31, 2022 2.02 Bn
Sep 30, 2022 1.61 Bn
Jun 30, 2022 1.42 Bn
Mar 31, 2022 1.28 Bn
Dec 31, 2021 2.37 Bn
API Access

Bristol Myers Squibb Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=BMY&period=max&api_key=YOUR_API_KEY